Wu G, Lu Z H, Wei T J, Howells R D, Christoffers K, Ledeen R W
Department of Neurosciences, UMDNJ-New Jersey Medical School, Newark 07103, USA.
Ann N Y Acad Sci. 1998 Jun 19;845:126-38. doi: 10.1111/j.1749-6632.1998.tb09666.x.
Our studies with cultured cells have provided new insight into the particular role of GM1 in regulating excitatory opioid responses. GM1 is significantly elevated in chronic opioid-treated cells via Gs/adenylyl cyclase activation. Such GM1 elevation promotes coupling of opioid receptor with Gs, resulting in attenuation of inhibitory opioid effects and induction of a sustained excitatory response. Application of exogenous GM1, but not other gangliosides, induces excitatory opioid responses not only in neurons and neuroblastoma cells that bear intrinsic opioid receptors but also in nonneuronal cells that are transfected with delta-opioid receptor. The latter system provides evidence that allosteric binding of GM1 changes receptor conformation from a Gi-coupled to a Gs-coupled mode. This is supported by preliminary experiments with a mutated delta-opioid receptor.
我们对培养细胞的研究为GM1在调节兴奋性阿片样物质反应中的特殊作用提供了新的见解。通过Gs/腺苷酸环化酶激活,慢性阿片样物质处理的细胞中GM1显著升高。这种GM1升高促进了阿片样物质受体与Gs的偶联,导致抑制性阿片样物质作用减弱并诱导持续的兴奋性反应。应用外源性GM1而非其他神经节苷脂,不仅在具有内在阿片样物质受体的神经元和神经母细胞瘤细胞中,而且在转染了δ-阿片样物质受体的非神经元细胞中诱导兴奋性阿片样物质反应。后一种系统提供了证据,表明GM1的变构结合将受体构象从Gi偶联模式转变为Gs偶联模式。这得到了对突变的δ-阿片样物质受体进行的初步实验的支持。